Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2005; 51(1): 72-76

T-[sup]786[/sup] c promoter allelicpolymorphism of endothelialno-synthase gene as genetic predictorof acute coronary syndrome

V.E.Dosenko, V.Yu.Zagoriy, Ya.M.Lutay, A.N.Parkhomenko, A.A.Moibenko

    О.О. Bogomolets Institute of Physiology National Academyof Sciences of Ukraine, Kyiv



Abstract

Frequency of promoter endothelial NO-synthase gene allelic polymorphism by using polymerase chain reaction and restriction fragment length polymorphism (RFLP-PCR) was determined in 221 patients with acute coronary syndrome (ACS) and in 83 almost healthy subjects. Data obtained indi- cate that different promoter allelic variant frequency differs significantly in patients with ACS and in control group. Correlation of normal homozygotes (Т/Т), heterozygotes (Т/С) and pathologic homozysotes (С/С) was 48%, 36% and 16% respectively in patients, and in control it was 48%, 46%, 6% (Р<0.05 by c2-test). Thus, in patients with ACS in Ukrai- nian population pathologic С/С variants of 5’- flanking region of eNOS gene were found 2.7-times more often in ACS pa- tients, than in control. This allows us to suggest, that this allelic polymorphism can be considered as one of genetic risk factors of ACS development.

Full text: (PDF, in Ukrainian)

References

  1. Горбунова В.Н., Баранов В.С. Введение в молеку-лярную диагностику и генотерапию наследственныхзаболеваний. – СПб.: Спец. литература, 1997. – 287 с.
  2. Досенко В.Є., Загорій В.Ю., Мойбенко О.О.,Пархоменко О.М. Патофізіологічні аспекти гене-тичного поліморфізму ендотеліальної NO-синтази //Фізіол. журн. – 2002. – 48, №6. – С. 86–102.
  3. Alvarez R., Gonzalez P., Batalla A. et al. Associationbetween the NOS3 (-786 T/C) and the ACE (I/D) DNAgenotypes and early coronary artery disease // NitricOxide. – 2001. –5, № 4. – P. 343–348.
  4. Bertrand M.E., Simoons M.L., Fox K.A. et al.Management of acute coronary syndromes in patientspresenting without persistent ST-segment elevation.The Task Force on the Management of Acute CoronarySyndromes of the European Society of Cardiology //Eur. Heart J. – 2002. – 23. – P. 1809–1840.
  5. Braunwald E., Antman E.M., Brooks N.H. et al. ACC/AHA guidelinesfor the management of patients withunstable angina and non ST-elevation myocardialinfarction: Executive summary and Recommendations. Areport of the American College of Cardiology / AmericanHeart Association task force on practice guidelines(committee on management of patients with unstableangina) // Circulation. – 2000. – 102. – P. 1193–1209.
  6. Casas J.P., Bautista L.E., Humphries S.E., HingoraniA.D. Endothelial nitric oxide synthase genotype andischemic disease. Meta-analysis of 26 studies involving23028 subjects // Ibid. – 2004. – 109. – P. 1359–1365.
  7. Erbs S., Baither Y., Linke A. et al. Promoter but notexon polymorphism of endothelial nitric oxide syn-thase affects training-induced correction of endothelialdysfunction // Arterioscler. Thromb. Vasc. Biol. – 2003. –23. – P. 1814–1819.
  8. Ghilardi G., Biondi M.L., DeMonti M. et al. Indepen-dent risk factor for moderate to severe internal carotidartery stenosis: T786C mutation of endothelial nitricoxide synthase gene // Clin. Chem. – 2002. – 48, № 7. –P. 989–993.
  9. 9. Jeerooburkhan N., Jones L.C., Bujac S. et al. Geneticand environmental determinants of plasma nitrogenoxides and risk of ischemic heart disease // Hyper-tension. – 2001. – 38. – P.1054–1061.
  10. 10. Miyamoto Y., Saito Y., Nakayama M. et al. Replica-tion protein A1 reduces transcription of the endothe-lial nitric oxide synthase gene containing a -786T—>Cmutation associated with coronary spastic angina //Hum. Mol. Genet. – 2000. – 9, № 18. – P. 2629–2637.
  11. Nakayama M., Yasue H., Yoshimura M. et al. T-786--С Mutation in the 5'-flanking region of the endothelialnitric oxide synthase gene is associated with coronaryspasm // Circulation. – 1999. –99. – P. 2864–2870.
  12. Nakayama M., Yasue H., Yoshimura M. et al. T(-786)—> C mutation in the 5'-flanking region of the endothelialnitric oxide synthase gene is associated with myocardialinfarction, especially without coronary organic steno-sis // Amer. J. Cardiol. – 2000. –86, № 6. – P.628–634.
  13. Nasreen S., Nabika T., Shibata H. et al. T-786C poly-morphism in endothelial NO synthase gene affects ce-rebral circulation in smokers: possible gene-environ-mental interaction // Arterioscler. Thromb. Vasc. Biol. –2002. – 22, № 4. – P. 605–610.
  14. Park K.W., You K.H., Oh S. et al. Association of en-dothelial constitutive nitric oxide synthase gene poly-morphism with acute coronary syndrome in Koreans // Heart. – 2004. – 90. – P. 282–285.
  15. Sing C.F., Stengard J.H., Kardia S.L.R. Genes,environment, and cardiovascular disease // Arterioscler.Thromb. Vasc. Biol. – 2003. – 23. – P. 1190–1196.
  16. Tanus-Santos J.E., Desai M., Flockhart D.A. Effectsof ethnicity on the distribution of clinically relevantendothelial nitric oxide variants // Pharmacogenetics. –2001. – 11, № 8. – P. 719–725.
  17. World Health Organization. Nomenclature and criteriafor diagnosis of ischemic heart disease // Circulation. –1979. – 59. – P.607–609.
  18. Yoshimura M., Yasue H., Nakayama M. et al. Geneticrisk factors for coronary artery spasm: significance ofendothelial nitric oxide synthase gene T-786—>C andmissense Glu298Asp variants // J. Investig. Med. –2000. – 48, № 5. – P.367–374.
© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.